Gaudium IVF & Women Health
add_icon

Gaudium IVF & Women Health

95.13
+5.96
(6.68%)
Market Cap
692.42 Cr
PE Ratio
28.49
Volume
54,27,074.00
Day High - Low
99.80 - 88.68
52W High-Low
99.75 - 69.18
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
692.42 Cr
EPS
3.12
PE Ratio
28.49
PB Ratio
4.35
Book Value
20.45
EBITDA
28.90
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
41.31
Debt to Equity
0.52
Forecast For
Actual

Company News

View All News
Caret
neutral
Gaudium IVF and Women Health Limited submits compliance certificate under SEBI regulations for Q4FY26, with registrar confirming non-applicability due to full dematerialization.
neutral
Gaudium IVF submits additional disclosures to BSE regarding ₹29.21 crore arbitration case after court appointed Justice Nitin Jamdar as sole arbitrator, explaining delay in disclosure due to weekend court order.
positive
Gaudium IVF introduces AI-driven embryology systems SiD and ERICA in collaboration with UK-based IVF 2.0, marking India's first AI-led infertility treatment integration.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,404.70
#1 23,536.45
43.86
#1 2,554.80
11.28
#1 492
-6.83
60.71
981.80
10,102.40
62.74
699.70
23.06
144
22.38
62.23
468.10
9,705.01
56.01
1,346.30
10.64
146
33.65
58.88
399.00
6,350.70
45.95
702.20
20.80
91
47.37
60.09
560.30
5,622.09
77.63
769.90
33.97
67
60.20
56.24
595.75
1,932.53
24.00
742.70
16.70
78
-21.13
50.38
275.15
1,433.00
41.99
255.90
15.11
31
20.00
60.86
596.30
1,165.37
17.94
147.80
#1 134.60
19
#1 520.00
52.94
1,217.10
1,044.59
#1 17.73
111.60
28.72
48
65.93
44.85
269.20
856.34
29.59
1,170.80
-18.47
-134
101.06
43.80
Growth Rate
Revenue Growth
32.22 %
Net Income Growth
15.06 %
Cash Flow Change
153.49 %
ROE
-17.21 %
ROCE
-15.64 %
EBITDA Margin (Avg.)
-15.34 %

Quarterly Financial Results

Quarterly Financials
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
14
27
18
32
25
Expenses
9
18
13
18
18
EBITDA
6
9
5
14
7
Operating Profit %
39 %
33 %
29 %
43 %
27 %
Depreciation
1
0
1
1
1
Interest
0
0
1
1
1
Profit Before Tax
5
8
4
13
5
Tax
1
2
1
3
1
Net Profit
3
7
3
9
4
EPS in ₹
0.55
1.07
0.51
1.53
0.59

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
18
37
57
89
Fixed Assets
4
18
19
18
Current Assets
14
18
38
54
Capital Work in Progress
0
0
0
7
Investments
0
0
0
5
Other Assets
14
18
39
58
Total Equity & Liabilities
18
37
57
89
Current Liabilities
6
10
20
38
Non Current Liabilities
3
4
4
4
Total Equity
9
23
33
46
Reserve & Surplus
8
22
32
16
Share Capital
1
1
1
31

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
0
14
-3
-5
Investing Activities
-1
-16
-5
-15
Operating Activities
-1
24
3
9
Financing Activities
3
5
-1
2

Share Holding

% Holding
Jan 2025
Sept 2025
Feb 2026
Promoter
99.98 %
99.98 %
71.29 %
FIIs
0.00 %
0.00 %
9.24 %
DIIs
0.00 %
0.00 %
5.11 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
13.52 %
Others
0.02 %
0.02 %
0.84 %
No of Share Holders
7
7
7

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
18 Mar 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
18 Mar 2026 81.09 85.19

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20182 days ago
Gaudium IVF And Women Health Limited Has Updated The Exchange On The Query Received From BSE Limited Vide Its Email Dated April 07 2026 Seeking Additional Details For Corporate Announcement Dated April 06 2026 Filed Under Regulation 30 Of SEBI (LODR) Regu5 days ago
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)6 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 01, 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015 ( "Listing Regulations")Apr 01, 2026
Closure of Trading WindowMar 28, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 19, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 19, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMar 18, 2026
Board Meeting Outcome for Board Meeting Outcome For Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Mar 18, 2026
Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Mar 18, 2026
Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025Mar 12, 2026
Intimation Under Regulation 8(2) Of The Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015Mar 02, 2026
Intimation Under Regulation 7(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)Mar 02, 2026
Intimation Under Regulation 6(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 02, 2026
Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations")Mar 02, 2026
Closure of Trading WindowMar 02, 2026
Listing of Equity Shares of Gaudium IVF and Women Health LtdFeb 27, 2026

Technical Indicators

RSI(14)
Neutral
64.12
ATR(14)
Volatile
7.18
STOCH(9,6)
Neutral
71.26
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
0.00
ADX(14)
Weak Trend
0.00
UO(9)
Bullish
0.00
ROC(12)
Uptrend And Accelerating
23.48
WillR(14)
Overbought
-15.25